We invest at the earliest stages, entering at Seed or Series A in creative bioscience companies harnessing the power of cells and computation to scale solutions in human health and sustainability. Our team has spent the last decade working with founders to make science fiction a reality. Our portfolio has grown leather without the cow, developed therapeutics to alter the course of Alzheimer’s and transformed industrial carbon dioxide emissions into useful products.

At Breakout Ventures, we believe cells are the engine of the next decade as the tools, technologies and, most importantly, talent from across industries are brought to bear on biology and chemistry in surprising ways.